Stockscreener 앱 받기
144.00
0.91%
1.30
시간 외 거래:
144.00
전일 마감가:
$142.70
열려 있는:
$144.01
하루 거래량:
1.94M
Relative Volume:
0.69
시가총액:
$31.04B
수익:
$606.42M
순이익/손실:
$-1.28B
주가수익비율:
-22.49
EPS:
-6.403
순현금흐름:
$-997.58M
1주 성능:
+3.21%
1개월 성능:
-10.56%
6개월 성능:
-0.53%
1년 성능:
+82.42%
1일 변동 폭
$141.80
$144.88
1주일 범위
$138.01
$147.38
52주 변동 폭
$60.40
$212.75
Insmed Inc Stock (INSM) Company Profile
명칭
Insmed Inc
전화
908-977-9900
주소
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Compare INSM vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
144.00 | 30.76B | 606.42M | -1.28B | -997.58M | -6.403 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-16 | 재개 | Jefferies | Buy |
| 2026-01-28 | 개시 | Barclays | Overweight |
| 2026-01-23 | 개시 | Roth Capital | Buy |
| 2025-12-19 | 재개 | Truist | Buy |
| 2025-12-04 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-10-28 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-10-20 | 개시 | Wells Fargo | Overweight |
| 2025-08-20 | 개시 | William Blair | Outperform |
| 2025-08-13 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | 개시 | Jefferies | Buy |
| 2025-02-25 | 개시 | RBC Capital Mkts | Outperform |
| 2024-04-23 | 개시 | Truist | Buy |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2023-12-08 | 개시 | Wells Fargo | Overweight |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-07-26 | 개시 | Guggenheim | Buy |
| 2022-12-09 | 개시 | Mizuho | Buy |
| 2022-12-07 | 개시 | Barclays | Overweight |
| 2022-11-18 | 개시 | BofA Securities | Buy |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2021-12-06 | 개시 | JP Morgan | Overweight |
| 2021-10-19 | 재개 | Monness Crespi & Hardt | Buy |
| 2021-10-19 | 재개 | Morgan Stanley | Overweight |
| 2021-10-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2020-12-17 | 개시 | Berenberg | Buy |
| 2020-10-12 | 재개 | Stifel | Buy |
| 2019-09-03 | 개시 | Goldman | Buy |
| 2019-04-09 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-15 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-01-02 | 개시 | Canaccord Genuity | Buy |
| 2018-08-06 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | 개시 | Goldman | Neutral |
| 2018-04-23 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | 개시 | Morgan Stanley | Overweight |
| 2018-01-18 | 개시 | Credit Suisse | Neutral |
| 2017-09-05 | 재확인 | Evercore ISI | Outperform |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-07-11 | 개시 | Robert W. Baird | Outperform |
| 2016-03-15 | 개시 | Stifel | Buy |
| 2015-11-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2015-10-06 | 재확인 | H.C. Wainwright | Buy |
| 2015-06-09 | 개시 | Citigroup | Neutral |
| 2014-03-26 | 재확인 | HC Wainwright | Buy |
모두보기
Insmed Inc 주식(INSM)의 최신 뉴스
William Lewis reports share sales at INSM (NASDAQ: INSM) in Form 144 - Stock Titan
Insmed (INSM) poised for 2026 upside with potential $1.3B Arikayce sales boost, Roth/MKM initiates buy - MSN
Artisan Small Cap Fund Sold Insmed (INSM) on Valuation Consideration - Yahoo Finance
Novo Holdings A S Sells 480,000 Shares of Insmed, Inc. $INSM - MarketBeat
Long Focus Capital Management LLC Sells 182,200 Shares of Insmed, Inc. $INSM - MarketBeat
Millennium Management LLC Has $336.42 Million Stake in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Stock Position Decreased by Jain Global LLC - MarketBeat
Fred Alger Management LLC Has $13.54 Million Holdings in Insmed, Inc. $INSM - MarketBeat
Granahan Investment Management LLC Reduces Holdings in Insmed, Inc. $INSM - MarketBeat
INSM: Jefferies Upgrades Insmed to Buy, Sets Price Target at $22 - GuruFocus
Insmed (NASDAQ:INSM) Coverage Initiated by Analysts at Jefferies Financial Group - MarketBeat
HighVista Strategies LLC Has $7.19 Million Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Holocene Advisors LP Trims Stake in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM is Darwin Global Management Ltd.'s Largest Position - MarketBeat
506,245 Shares in Insmed, Inc. $INSM Bought by Bank of Nova Scotia - MarketBeat
Aquatic Capital Management LLC Has $10.99 Million Stake in Insmed, Inc. $INSM - MarketBeat
Eventide Asset Management LLC Sells 191,387 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Stake Increased by Brevan Howard Capital Management LP - MarketBeat
Cinctive Capital Management LP Buys 33,307 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Stock Holdings Reduced by Baker BROS. Advisors LP - MarketBeat
Algert Global LLC Purchases 62,802 Shares of Insmed, Inc. $INSM - MarketBeat
Suvretta Capital Management LLC Has $31.36 Million Stake in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Sold by Van ECK Associates Corp - MarketBeat
Landscape Capital Management L.L.C. Purchases Shares of 28,194 Insmed, Inc. $INSM - MarketBeat
Russell Investments Group Ltd. Has $23.97 Million Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Bought by Swiss National Bank - MarketBeat
Insmed, Inc. $INSM Stock Position Trimmed by Franklin Resources Inc. - MarketBeat
First Trust Advisors LP Purchases 193,254 Shares of Insmed, Inc. $INSM - MarketBeat
INSM Stock Price, Quote & Chart | INSMED INC (NASDAQ:INSM) - ChartMill
MDA 2026: Insmed launches Phase 1 trial of INS1202 gene therapy for ALS - ALS News Today
Atika Capital Management LLC Makes New Investment in Insmed, Inc. $INSM - MarketBeat
FOMO Trade: Is Insmed Incorporated stock a buy or sellEarnings Summary Report & Expert Verified Movement Alerts - baoquankhu1.vn
Insmed at Leerink Global Healthcare Conference: Strategic Insights - Investing.com India
Insmed at Leerink Global Healthcare Conference: Strategic Insights By Investing.com - Investing.com Nigeria
INSM: ENCORE and BRINSUPRI drive growth as new pipeline assets advance toward major milestones - TradingView
Capital International Investors Raises Stock Position in Insmed, Inc. $INSM - MarketBeat
INSM stock jumps on 2025 preliminary sales, 2026 goals announced - MSN
Fieldview Capital Management LLC Purchases Shares of 20,229 Insmed, Inc. $INSM - MarketBeat
Rhenman & Partners Asset Management AB Has $18.99 Million Stake in Insmed, Inc. $INSM - MarketBeat
Neo Ivy Capital Management Has $1.40 Million Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Neuberger Berman Group LLC Raises Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. (NASDAQ:INSM) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Victory Capital Management Inc. Boosts Position in Insmed, Inc. $INSM - MarketBeat
Is Insmed Incorporated stock a safe investment in uncertain marketsInsider Selling & Free Technical Pattern Based Buy Signals - Naître et grandir
Insmed Incorporated (INSM) Price Target Raised to $211 at BofA - Finviz
Institution Moves: What are the future prospects of Insmed IncorporatedBear Alert & Accurate Buy Signal Alerts - baoquankhu1.vn
William Lewis Sells 10,699 Shares of Insmed (NASDAQ:INSM) Stock - MarketBeat
Insmed Breaks Below 200-Day Moving AverageNotable for INSM - Nasdaq
INSMED Chair and CEO William Lewis Sells Over 10,000 Shares - TradingView
Insmed (NASDAQ: INSM) CEO reports option exercises and 10,699-share sale - Stock Titan
Insmed (NASDAQ: INSM) director reports bona fide 100-share stock gift - Stock Titan
Insmed Inc (INSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
0.77%
자본화:
|
볼륨(24시간):